Senti Biosciences Holdings (SNTI) Shares Outstanding (2021 - 2025)
Senti Biosciences Holdings (SNTI) posted quarterly Shares Outstanding (Entity) of $22.5 million for Q4 2025, up 365.59% year-over-year from $4.8 million in Q4 2024, and down 14.48% quarter-over-quarter from $26.3 million in Q3 2025.
Senti Biosciences Holdings (SNTI) Shares Outstanding (2021 - 2025) Analysis & Trends
Senti Biosciences Holdings' Shares Outstanding (Entity) history runs 5 years deep, the most recent figure standing at $22.5 million for Q4 2025.
- In Q4 2025, Shares Outstanding (Entity) rose 365.59% year-over-year to $22.5 million; the TTM figure through Dec 2025 stood at $22.5 million (up 365.59% YoY), while the FY2025 annual figure was $22.5 million, up 365.59% from the prior year.
- Shares Outstanding (Entity) for Q4 2025 stood at $22.5 million, down from $26.3 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $26.3 million in Q3 2025, with the low at $291228.0 in Q4 2021.
- The 5-year median for Shares Outstanding (Entity) is $4.4 million (2023), against an average of $6.9 million.
- Peak annual rise in Shares Outstanding (Entity) reached 796.58% in 2022, while the deepest fall reached 43.3% in 2022.
- Senti Biosciences Holdings' Shares Outstanding (Entity) stood at $291228.0 in 2021, then soared by 796.58% to $2.6 million in 2022, then soared by 75.02% to $4.6 million in 2023, then rose by 5.67% to $4.8 million in 2024, then jumped by 365.59% to $22.5 million in 2025.
- Business Quant data shows SNTI's Shares Outstanding (Entity) at $22.5 million in Q4 2025, $26.3 million in Q3 2025, and $26.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.19 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 398.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 111.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.61 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 241.70 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 217.35 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 445.06 Mn |
| 10 | Senti Biosciences Holdings | 12.06 Mn | 12.06 Mn | - | 31.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.48 Mn |
| Sep 30, 2025 | 26.23 Mn |
| Jun 30, 2025 | 26.08 Mn |
| Mar 31, 2025 | 10.01 Mn |
| Dec 31, 2024 | 4.60 Mn |
| Sep 30, 2024 | 4.58 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 4.57 Mn |
| Dec 31, 2023 | 4.44 Mn |
| Sep 30, 2023 | 4.45 Mn |
| Jun 30, 2023 | 4.43 Mn |
| Mar 31, 2023 | 4.41 Mn |
| Dec 31, 2022 | 2.61 Mn |
| Sep 30, 2022 | 4.34 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 2.37 Mn |
| Dec 31, 2021 | 291,228.00 |
| Sep 30, 2021 | 2.95 Mn |
| Jun 30, 2021 | 2.19 Mn |
| Mar 31, 2021 | 500,000.00 |